Sympathetic Ophthalmia Successfully Controlled with Methotrexate

Main Article Content

Adrian C Tsang
Chloe Gottlieb


This is a case of sympathetic ophthalmia in a 31 year old man presenting five months after a penetrating globe injury to his left eye. Vision loss in the right eye was unexpected and the patient’s uveitis became refractory to prednisone treatment. The patient was successfully treated and his uveitis remains quiet with combined methotrexate and prednisone therapy. This case was well documented with fluorescein angiography and fundus photography throughout the treatment course.


Article Details

Case Report & Elective report


1.Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol. 2000;84:259–63.

2.Vote BJ, Hall A, Cairns J, Buttery R. Changing trends in sympathetic ophthalmia. Clin Experiment Ophthalmol 2004; 32(5):542–545.

3.Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am J Ophthalmol. 2000;130(4):492-513.

4.Sampangi R, Venkatesh P, Mandal S, Garg SP. Recurrent neovascularization of the disc in sympathetic ophthalmia. Indian J Ophthalmol. 2008;56(3):237.

5. Chang GC, Young LH. Sympathetic Ophthalmia. Semin Ophthalmol. 2011; 26(4-5), 316–320.